Skip to main content
OpenTrials
Completed

NCT Number: NCT06276790

Objective Analysis of Caesarean Scar Pregnancy

This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Caesarean Scar Pregnancy Ultrasound Scoring System

Age range

20 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Chengde Central Hospital

Chengde, 067000, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • history of at least one previous caesarean section
  • symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy
  • amenorrhea ≤84 days
  • ultrasound examination suggesting a single gestational sac with intact morphology
  • stable maternal vital signs

Exclusion criteria

  • mass-type caesarean scar pregnancy
  • previous medication or surgical treatment before ultrasound examination
  • haemodynamically unstable patients
  • patients with surgical contraindications
  • incomplete or lost follow-up clinical data
  • patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia

Treatment and study plan

ultrasound-guided/hysteroscopic curettage

Procedure

ultrasound-guided/hysteroscopic curettage

Procedure/Surgery: laparoscopic removal of the pregnancy lesion

Procedure

laparoscopic removal of the pregnancy lesion

Primary outcomes

  1. intraoperative blood loss

    Time frame: during surgery

    The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.

  2. length of hospital stay

    Time frame: Within 1 week

    Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.

  3. serum β-HCG levels

    Time frame: Within 2 weeks after the operation

    The time taken for serum β-HCG levels to return to normal

Sponsors and collaborators

Lead sponsor

Chengde Central Hospital

Other Gov

Registry information

Official study title

The Predictive Value of an Ultrasound Quantitative Scoring System for Treatment Method Selection in Patients With Caesarean Scar Pregnancy: A Single-Centre Retrospective Study

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Feb 26, 2024
Registry last updated
Feb 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.